BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12700687)

  • 1. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response.
    Yu YW; Chen TJ; Hong CJ; Chen HM; Tsai SJ
    Neuropsychopharmacology; 2003 Jun; 28(6):1182-5. PubMed ID: 12700687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response.
    Yu YW; Tsai SJ; Hong CJ; Chen TJ; Chen MC; Yang CW
    Neuropsychopharmacology; 2005 Sep; 30(9):1719-23. PubMed ID: 15956990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.
    Tsai SJ; Cheng CY; Yu YW; Chen TJ; Hong CJ
    Am J Med Genet B Neuropsychiatr Genet; 2003 Nov; 123B(1):19-22. PubMed ID: 14582140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of interleukin-1 beta gene polymorphism and childhood maltreatment on antidepressant treatment].
    Chen Y; Zhang Z; Xu Z; Pu M; Geng L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):801-4. PubMed ID: 26663052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
    Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
    Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders.
    Hong CJ; Wang YC; Tsai SJ
    J Neural Transm (Vienna); 2002 Sep; 109(9):1209-14. PubMed ID: 12203048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder.
    Jazayeri S; Keshavarz SA; Tehrani-Doost M; Djalali M; Hosseini M; Amini H; Chamari M; Djazayery A
    Psychiatry Res; 2010 Jun; 178(1):112-5. PubMed ID: 20466437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder.
    Gudayol-Ferré E; Herrera-Guzmán I; Camarena B; Cortés-Penagos C; Herrera-Abarca JE; Martínez-Medina P; Cruz D; Hernández S; Genis A; Carrillo-Guerrero MY; Avilés Reyes R; Guàrdia-Olmos J
    J Affect Disord; 2010 Dec; 127(1-3):343-51. PubMed ID: 20584552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of serotonin 1B receptor (A-161T) genetic polymorphism and suicidal behaviors and response to fluoxetine in major depressive disorder.
    Tsai SJ; Hong CJ; Yu YW; Chen TJ; Wang YC; Lin WK
    Neuropsychobiology; 2004; 50(3):235-8. PubMed ID: 15365222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder.
    Lee SH; Lee KJ; Lee HJ; Ham BJ; Ryu SH; Lee MS
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):140-5. PubMed ID: 15823158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders.
    Wu WH; Huo SJ; Cheng CY; Hong CJ; Tsai SJ
    Neuropsychobiology; 2001; 44(4):172-5. PubMed ID: 11702016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response.
    Tzang RF; Hong CJ; Liou YJ; Yu YW; Chen TJ; Tsai SJ
    Neurosci Lett; 2008 Dec; 447(1):92-5. PubMed ID: 18838110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene.
    Choi MJ; Lee HJ; Lee HJ; Ham BJ; Cha JH; Ryu SH; Lee MS
    Neuropsychobiology; 2004; 49(1):38-41. PubMed ID: 14730199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of the apo epsilon2 allele in major depressive disorder in Taiwanese.
    Fan PL; Chen CD; Kao WT; Shu BC; Lung FW
    Acta Psychiatr Scand; 2006 Jan; 113(1):48-53. PubMed ID: 16390369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.